We are live on ! Find out more
TI

Telemetry Investments Portfolio holdings

AUM $63.3M
1-Year Est. Return 0.06%
This Fund
S&P 500
This Quarter Est. Return
+4.93%
1 Year Est. Return
+0.06%
3 Year Est. Return
+77.42%
5 Year Est. Return
+156.79%
10 Year Est. Return
AUM
$262M
AUM Growth
-$17.6M
Cap. Flow
-$41.4M
Cap. Flow %
-15.8%
Top 10 Hldgs %
58.42%
Holding
182
New
46
Increased
31
Reduced
25
Closed
52

Sector Composition

Rank Sector Weight
1 Healthcare 7.43%
2 Communication Services 2.9%
3 Consumer Discretionary 1.78%
4 Technology 1.37%
5 Utilities 1.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGT icon
101
Target
TGT
$65.5B
$215K 0.08%
+3,300
New +$199K
TGT icon
102
PUT
Target
TGT
$65.5B
$215K 0.08%
+3,300
New +$199K
ACOR
103
PUT
DELISTED
Acorda Therapeutics
ACOR
$214K 0.08%
+83
New +$236K
BLPH
104
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$205K 0.08%
+5,295
New +$139K
CRIS icon
105
Curis
CRIS
$9.41M
$204K 0.08%
146
+46
+46% +$108K
DUK icon
106
Duke Energy
DUK
$101B
$202K 0.08%
+2,400
New +$210K
NVAX icon
107
CALL
Novavax
NVAX
$1.21B
$186K 0.07%
7,500
-2,500
-25% -$61K
NIHD
108
DELISTED
NII Holdings, Inc. Common Stock
NIHD
$183K 0.07%
432,052
-82,948
-16% -$31.4K
GDP
109
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
$174K 0.07%
+15,958
New +$164K
CPN
110
DELISTED
Calpine Corporation
CPN
$166K 0.06%
11,000
+1,000
+10% +$15K
BCS icon
111
CALL
Barclays
BCS
$91B
$164K 0.06%
15,690
BCS icon
112
PUT
Barclays
BCS
$91B
$164K 0.06%
15,690
IMDZ
113
DELISTED
Immune Design Corp.
IMDZ
$153K 0.06%
+39,295
New +$214K
AUD
114
DELISTED
Audacy, Inc.
AUD
$145K 0.06%
+13,471
New +$153K
BCS icon
115
Barclays
BCS
$91B
$142K 0.05%
13,598
-2,092
-13% -$20.3K
CVE icon
116
Cenovus Energy
CVE
$51.6B
$99K 0.04%
+10,800
New +$105K
AGI icon
117
Alamos Gold
AGI
$12.1B
$97K 0.04%
+14,825
New +$96.7K
ACFC
118
DELISTED
Atlantic Coast Financial Corporation
ACFC
$96K 0.04%
+10,219
New +$92.1K
OREX
119
DELISTED
Orexigen Therapeutics, Inc.
OREX
$83K 0.03%
+64,464
New +$105K
AMRN
120
CALL
Amarin Corp
AMRN
$293M
$40K 0.02%
+500
New +$34.5K
RAD
121
DELISTED
Rite Aid Corporation
RAD
$22K 0.01%
550
-200
-27% -$7.14K
AAPL icon
122
Apple
AAPL
$4.99T
-28,280
Closed -$1.09M
ADBE icon
123
Adobe
ADBE
$99B
-1,945
Closed -$290K
ADAP
124
DELISTED
Adaptimmune Therapeutics
ADAP
-20,710
Closed -$170K
AMT icon
125
American Tower
AMT
$79.9B
-1,660
Closed -$227K

Similar funds

Telemetry Investments's Q4 2017 Portfolio in Review

As of Q4 2017, Telemetry Investments held 182 positions worth $262M, down 6.3% from $280M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Telemetry Investments withdrew a net $41.4M in Q4 2017, closing 52 positions and reducing 25 holdings. Its most notable exit was Kite Pharma, Inc., an estimated $3.07M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 7.4% of assets, down from 7.9% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, Telemetry Investments opened a new position in Buffalo Wild Wings, Inc. worth $2.28M.

  • Telemetry Investments's largest Q4 2017 buy was Buffalo Wild Wings, Inc.: 14,605 shares worth $2.28M.
  • Telemetry Investments added most to Time Warner Inc in Q4 2017, an estimated $2.16M increase.
  • Telemetry Investments's biggest Q4 2017 reduction was Acceleron Pharma, cutting an estimated $604K.
  • Telemetry Investments fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $3.07M.
  • Telemetry Investments's ten largest holdings make up 58% of its $262M portfolio in Q4 2017.
  • Telemetry Investments opened 46 new positions and closed 52 in Q4 2017.
  • Telemetry Investments's portfolio value fell 6.3% quarter-over-quarter to $262M.

Based on Telemetry Investments's 13F filing for Q4 2017, filed 14 Feb 2018.